Netrin-1 expression and targeting in multiple myeloma

References

• Kennedy TE, Serafini T, de la Torre JR, et al. Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord. Cell. 1994;78(3):425–435.
   PubMed Web of Science ®Google Scholar
• Leonardo ED, Hinck L, Masu M, et al. Vertebrate homologues of C. elegans UNC-5 are candidate netrin receptors. Nature. 1997;386(6627):833–838.
   PubMed Web of Science ®Google Scholar
• Palu E, Liesi P. Differential distribution of laminins in alzheimer disease and normal human brain tissue. J Neurosci Res. 2002;69(2):243–256.
   PubMed Web of Science ®Google Scholar
• Rama N, Goldschneider D, Corset V, et al. Amyloid precursor protein regulates netrin-1-mediated commissural axon outgrowth. J Biol Chem. 2012;287(35):30014–30023.
   PubMed Web of Science ®Google Scholar
• Sun J-H, Wang H-F, Zhu X-C, Alzheimer’s Disease Neuroimaging Initiative, et al. The impact of UNC5C genetic variations on neuroimaging in alzheimer’s disease. Mol Neurobiol. 2016;53(10):6759–6767.
   PubMed Web of Science ®Google Scholar
• Fang DC, Jass JR, Wang DX. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J Clin Pathol. 1998;51(8):593–596.
   PubMed Web of Science ®Google Scholar
• Kato H, Zhou Y, Asanoma K, et al. Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of the DCC gene. Br J Cancer. 2000;82(2):459–466.
   PubMed Web of Science ®Google Scholar
• Keino-Masu K, Masu M, Hinck L, et al. Deleted in colorectal cancer (DCC) encodes a netrin receptor. Cell. 1996;87(2):175–185.
   PubMed Web of Science ®Google Scholar
• Mehlen P, Guenebeaud C. Netrin-1 and its dependence receptors as original targets for cancer therapy. Curr Opin Oncol. 2010;22(1):46–54.
   PubMed Web of Science ®Google Scholar
• Llambi F, Causeret F, Bloch-Gallego E, et al. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. Embo J. 2001;20(11):2715–2722.
   PubMed Web of Science ®Google Scholar
• Koren R, Dekel Y, Sherman E, et al. The expression of DCC protein in female breast cancer. Breast Cancer Res Treat. 2003;80(2):215–220.
   PubMed Web of Science ®Google Scholar
• Shibata D, Reale MA, Lavin P, et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med. 1996;335(23):1727–1732.
   PubMed Web of Science ®Google Scholar
• Gao X, Honn KV, Grignon D, et al. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res. 1993;53(12):2723–2727.
   PubMed Web of Science ®Google Scholar
• Gao S, Xu W, Wan Y. [Loss of heterozygosity involving DCC gene in human colorectal cancers is correlated with the metastatic potential. Zhonghua Zhong Liu Za Zhi. 1996;18(4):250–252.
   PubMedGoogle Scholar
• Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol. 2006;12(2):192–198.
   PubMed Web of Science ®Google Scholar
• Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer. 2004;4(12):978–987.
   PubMed Web of Science ®Google Scholar
• Forcet C, Ye X, Granger L, et al. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc Natl Acad Sci USA. 2001;98(6):3416–3421.
   PubMed Web of Science ®Google Scholar
• Hedgecock EM, Culotti JG, Hall DH. The unc-5, unc-6, and unc-40 genes guide circumferential migrations of pioneer axons and mesodermal cells on the epidermis in C. elegans. Neuron. 1990;4(11):61–85. Jan
   PubMedGoogle Scholar
• Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990;247(4938):49–56.
   PubMed Web of Science ®Google Scholar
• Hilgers W, Song JJ, Haye M, et al. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers. Genes Chromosom Cancer. 2000;27(4):353–357.
   PubMed Web of Science ®Google Scholar
• Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 1998 May 15;280(5366):1086–1088.
   PubMed Web of Science ®Google Scholar
• Ogawa R, Yamamoto T, Hirai H, et al. Loss of SMAD4 promotes colorectal cancer progression by recruiting Tumor-Associated neutrophils via the CXCL1/8-CXCR2 axis. Clin Cancer Res. 2019;25(9):2887–2899. 01
   PubMed Web of Science ®Google Scholar
• Salovaara R, Roth S, Loukola A, et al. Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut. 2002;51(1):56–59.
   PubMed Web of Science ®Google Scholar
• Mehlen P, Rabizadeh S, Snipas SJ, et al. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature. 1998;395(6704):801–804.
   PubMed Web of Science ®Google Scholar
• Duman-Scheel M. Deleted in colorectal cancer (DCC) pathfinding: axon guidance gene finally turned tumor suppressor. Curr Drug Targets. 2012;13(11):1445–1453.
   PubMed Web of Science ®Google Scholar
• Grady WM. Making the case for DCC and UNC5C as tumor-suppressor genes in the Colon. Gastroenterology. 2007;133(6):2045–2049.
   PubMed Web of Science ®Google Scholar
• Broutier L, Creveaux M, Vial J, et al. Targeting netrin-1/DCC interaction in diffuse large B-cell and mantle cell lymphomas. EMBO Mol Med. 2016;8(2):96–104.
   PubMed Web of Science ®Google Scholar
• Abstract 2921: Preclinical characteristics of NP137, a first-in-class monoclonal antibody directed against netrin-1 and inducing dependence receptors-mediated cell death | Cancer Research. 2015. [Internet]. [cited 2020 Mar 1]. Available from: https://cancerres.aacrjournals.org/content/75/15_Supplement/2921
   Google Scholar
• Delloye-Bourgeois C, Brambilla E, Coissieux M-M, et al. Interference with netrin-1 and tumor cell death in non–small cell lung cancer. JNCI J Natl Cancer Inst. 2009;101(4):237–247.
   Web of Science ®Google Scholar
• Delloye-Bourgeois C, Fitamant J, Paradisi A, et al. Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med. 2009;206(4):833–847.
   PubMed Web of Science ®Google Scholar
• Paradisi A, Creveaux M, Gibert B, et al. Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death. EMBO Mol Med. 2013;5(12):1821–1834.
   PubMed Web of Science ®Google Scholar